𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-dose chemotherapy with autologous stem cell support for the treatment of advanced ovarian cancer — initial experience in Uppsala and Turku

✍ Scribed by Seija Grenman; Bengt Tholander; Kari Remes; Marjut Kauppila; Allan Rajamäki; Tarja-terttu Pelliniemi; Virpi Rantanen; Toivo Salmi; Kristina Carlsson; Martin Höglund; Gunnar ÖBerg; Bengt Simonson; Tuula Salmi

Book ID
109339370
Publisher
Informa plc
Year
1997
Tongue
English
Weight
560 KB
Volume
76
Category
Article
ISSN
0001-6349

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High dose chemotherapy with autologous s
High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma : Long term results for 105 patients
✍ Takao Shinozuka; Tsuyoshi Miyamoto; Toshinari Muramatsu; Takeshi Hirasawa; Masar 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

## BACKGROUND. In this study, the authors reviewed long term results and prognostic factors of high dose chemotherapy (HDC) with autologous stem cell support administered to 105 patients with epithelial ovarian carcinoma. ## METHODS. Prior to HDC, platinum-based chemotherapy was given to optimi

High-dose chemotherapy with hematopoieti
High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience
✍ A. Fléchon; P. Biron; J.P. Droz 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 105 KB 👁 2 views

## Germ -cell tumors (GCTs) are very chemosensitive and highly curable cancers. For the small proportion of patients who fail conventional chemotherapy (CT), high-dose CT (HDCT) was introduced in France and elsewhere in 1982-1984. We report here on the French experience with HDCT in GCTs. At the C